Jazz Acquires GW Pharma and Epidiolex, Other Potential Cannabinoids
uncategorized
Jazz Pharmaceuticals announced the signing of a definitive agreement for it to acquire GW Pharmaceuticals and holdings that include Epidiolex, an approved oral cannabinoid treatment for seizures in Lennox-Gastaut syndrome (LGS) patients. “We are ... Read more